Moderna's Covid-19 vaccine shows 93% efficacy through six months, and the company expects to complete its application for full US Food and Drug Administration approval this month, it said in a news release Thursday.
Moderna's Covid-19 vaccine shows 93% efficacy through six months, and the company expects to complete its application for full US Food and Drug Administration approval this month, it said in a news release Thursday.
